AI Breakthrough: How Boltz-2 Is Accelerating Drug Discovery by 1000x
Scientists at the Massachusetts Institute of Technology, in collaboration with the biotechnology startup Recursion and engineers from NVIDIA, have unveiled Boltz-2—a groundbreaking biomolecular AI system designed to radically accelerate drug discovery. Released under the...
